BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 5403122)

  • 1. [Thrombocyte function analysis in hyperlipoproteinemias].
    Zöller H; Schramm A; Gross W
    Blut; 1974 Jan; 28(1):24-32. PubMed ID: 4810901
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelet function in hyperlipoproteinemia.
    Carvalho AC; Colman RW; Lees RS
    N Engl J Med; 1974 Feb; 290(8):434-8. PubMed ID: 4359434
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary hyperlipemia: intra-platelet and serum NEFA. Their relation to hypercoagulability].
    Yañez-Polo MA; Muñoz-González J; C-Soriguer-Escofet F; Causse-Prado M; Lissen-Otero E; León-Castro J
    Minerva Med; 1974 Apr; 65(25):1329-39. PubMed ID: 4849473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmatic coagulation factors in hyperlipoproteinemias].
    Zöller H; Fromme K; Gross W
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):201-4. PubMed ID: 4360448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatty acid composition of the steroids of the main classes of beta-lipoproteins isolated by ultracentrifugation in normal and hyperglyceridemic subjects with or without associated atheroma].
    Jaillard J; Sézille G; Scherpereel P; Fruchart JC; Biserte G
    Pathol Biol (Paris); 1972 Jan; 20(1):51-6. PubMed ID: 4552030
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet adhesion before and after venous occlusion. A comparison between normal subjects, patients with primary "carbohydrate-induced" hypertriglyceridemia and patients with arteriosclerotic vascular disease.
    Holzknecht F; Spöttl F; Constantini R; Knapp E; Herbst M; Braunsteiner H
    Atherosclerosis; 1970; 11(1):105-17. PubMed ID: 5422745
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet function (aggregability, adhesivity) in atherosclerotic hyperlipidemic subjects].
    Loeper J; Rouffy J; Caen J; Sultan Y; Larrieu MJ
    Rev Atheroscler (Paris); 1969; 11(2):45-53. PubMed ID: 5403122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Can the reduction of blood lipids nfluence the occurrence of clinical atherosclerosis?].
    Válek J; Kuhn E
    Cesk Gastroenterol Vyz; 1970 Dec; 24(8):373-6. PubMed ID: 4924393
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipidemia characteristics in arterial hypertension].
    Neverov IV; Baĭmatova DD
    Sov Med; 1984; (6):46-9. PubMed ID: 6379903
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated remnant-like particle cholesterol concentration: a characteristic feature of the atherogenic lipoprotein phenotype.
    Twickler TB; Dallinga-Thie GM; Cohn JS; Chapman MJ
    Circulation; 2004 Apr; 109(16):1918-25. PubMed ID: 15117861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Abnormalities of lipoprotein in arteriosclerosis].
    Goto Y; Nakamura H; Nakaya N
    Saishin Igaku; 1972 Mar; 27(3):524-30. PubMed ID: 4259904
    [No Abstract]   [Full Text] [Related]  

  • 12. AHA Conference Report on Cholesterol. Intervention studies.
    Levy RI; Blankenhorn D; Davis CE; Gordon DJ; Furberg C; Huttunen J; Levine RJ; Passamani E; Yusuf S
    Circulation; 1989 Sep; 80(3):739-43. PubMed ID: 2670325
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.